FDA clears second patient for Neuralink implantation
- May 20, 2024
- 0
US Food and Drug Administration (FDA) allowed Neuralinkbillionaire Elon Musk’s company is implanting a brain chip in second people after the company offered to fix a problem with
US Food and Drug Administration (FDA) allowed Neuralinkbillionaire Elon Musk’s company is implanting a brain chip in second people after the company offered to fix a problem with the first patient, the Wall Street Journal reported Monday.
Last week, Reuters, citing people familiar with the situation, reported that the problem was identified by Neuralink, which small cables in the brain of his first patient they had left his positionThis is a problem that Elon Musk’s company has known about for years.
The company intends to solve the problem by inserting some of the device’s wires deeper into the brain, the WSJ report said, citing a person familiar with the company and the document.
Networks: X @neuralink
He The Neuralink procedure involves using a robot to surgically place the implant. According to Neuralinks, the brain-computer interface (BCI) in the region of the brain that controls movement intention. Implant It works by recording and decoding electrical signals from the brain. using more than 2 thousand electrodes implanted in the area of the motor cortex.
Neuralink’s path to development brain implant technology It was full of problems and obstacles. The company, founded by Elon Musk, has faced initial setbacks that highlight the complexity inherent in this kind of innovation. However, Musk has big ambitions for Neuralink and has said that will facilitate rapid surgical installation of its chip devices for the treatment of diseases such as obesityHe autism, depression And schizophrenia.
Neuralink and the FDA did not immediately respond to Reuters’ request for comment on whether the implant could be approved for a second patient.
It takes pioneers to redefine the boundaries of human possibility.
If you have quadriplegia and would like to learn new ways to control your computer, we invite you to take part in our clinical study. pic.twitter.com/svqfAkVV1M
— Neuralink (@neuralink) May 16, 2024
Reuters
Source: Aristegui Noticias
As an experienced journalist and author, Mary has been reporting on the latest news and trends for over 5 years. With a passion for uncovering the stories behind the headlines, Mary has earned a reputation as a trusted voice in the world of journalism. Her writing style is insightful, engaging and thought-provoking, as she takes a deep dive into the most pressing issues of our time.
